# Indira IVF

Indira IVF is an Indian fertility clinic chain that provides in assisted reproductive technology, including in-vitro fertilization (IVF). Founded in 1988 by Dr. Ajay Murdia in Udaipur, Rajasthan, As of 2023, the company operated a network of over 150 centers across India.
The company, registered as Indira IVF Hospital Pvt. Ltd., provides fertility treatments. In 2023, private equity firm BPEA EQT acquired a majority stake.

## History

Indira IVF was established in 1988 by Dr. Ajay Murdia in Udaipur, Rajasthan. By 2023, the company operated a network of over 150 centers across India.
In July 2023, BPEA EQT acquired a controlling stake in Indira IVF from TA Associates. In January 2023, Bloomberg reported that Indira IVF's owners were considering a stake sale valuing the company at $1 billion, reflecting its growing market position in India's fertility sector.
In April 2024, the Competition Commission of India (CCI) approved the merger of Indira IVF and Spaceway Wellness Private Limited. This merger involved Spaceway, a special purpose vehicle, facilitating a 26% stake acquisition in Indira IVF. The CCI determined the merger would likely not adversely affect competition within India's fertility services market.

## Operations

Indira IVF operates a network of fertility clinics across India, offering assisted reproductive technology services. These include in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and intrauterine insemination (IUI), along with other related procedures such as egg and sperm freezing, donor programs, and genetic testing.
The company has expanded its presence across multiple cities, with over 150 centers as of 2023. It provides fertility treatments to individuals and couples experiencing reproductive challenges. In addition to its clinical services, Indira IVF engages in research and development related to reproductive medicine and collaborates with specialists in the field

## Regulatory and Sector Engagement

Indira IVF has engaged with Indian healthcare policy through participation in national bodies. Dr. Nitiz Murdia was appointed to the National Assisted Reproductive Technology and Surrogacy Board, a governmental organization overseeing reproductive technologies.
Dr. Ajay Murdia, the company's founder, has participated in public discourse on infertility in India, discussing its potential demographic impact.
Indira IVF has partnered with Safetree to offer an infertility insurance plan.
The company has expanded its operations internationally, opening a hospital in Kathmandu, Nepal. Plans have been announced for expansion into child and maternal healthcare.
Cüneyt Çetin's 2021 book, 'Embryologist', documents Indira IVF's contributions to advancements in assisted reproductive technology, focusing on genetic screening techniques such as preimplantation genetic testing (PGT) and non-invasive preimplantation genetic testing (niPGT).
Indira IVF's provision of fertility services during the COVID-19 pandemic is documented in Cüneyt Çetin's 2021 book, 'Frozen'.
Amrita Nandy's 2017 book, 'Motherhood and Choice', mentions Indira IVF in connection with the 'Nisantaanta Bharat Chodo Abhiyaan' campaign, citing a 2015 report in The Indian Express.